United States Biotechnology & Medical Research

Relay Therapeutics Inc (RLAY)

Track

Track

Relay Therapeutics experienced significant insider trading activity over the past ninety days, totaling thirty-one transactions. All recorded movements were sales, amounting to approximately $267.9 million. Key executives, including the CEO and CFO, executed planned divestments following the most recent earnings report, while major institutional stockholders also reduced their positions amid a 26.3% stock price increase.
Ticker: RLAY Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Relay Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.3
Bergstrom Donald A President, R&D Officer
Transaction date
Planned sale
Price
332.47
Quantity 69,817 -44.3%
Value US$4,569,701
3.3
Catinazzo Thomas Chief Financial Officer Officer
Transaction date
Planned sale
Price
328.00
Quantity 38,156 +9.6%
Value US$1,512,895
2.5
Patel Sanjiv President and CEO Executive Director
Transaction date
Planned sale
Price
177.03
Quantity 13,289 +31.2%
Value US$1,223,187
3.2
Rahmer Peter See remarks Officer
Transaction date
Planned sale
Price
20.03
Quantity 4,508 -2.0%
Value US$90,295
3.2
PETER RAHMER Officer Officer
Transaction date
Proposed sale
Price
20.57
Quantity 50,000
Value US$1,028,500
SVF Pauling (Cayman) Ltd Large shareholder
Transaction date
Sale
Price
19.40
Quantity 6,000,000 -21.5%
Value US$116,400,000
SVF Pauling (Cayman) Ltd Stockholder Large shareholder
Transaction date
Proposed sale
Price
20.57
Quantity 6,000,000
Value US$123,420,000
2.5
Patel Sanjiv President and CEO Executive Director
Transaction date
Planned sale
Price
20.33
Quantity 48,199 -7.8%
Value US$979,886
3.3
Catinazzo Thomas Chief Financial Officer Officer
Transaction date
Planned sale
Price
19.74
Quantity 17,717 -11.2%
Value US$349,734
SEKAR KATHIRESAN Director Non-Executive Director
Transaction date
Proposed sale
Price
19.57
Quantity 42,225
Value US$826,466
SEKAR KATHIRESAN Director Non-Executive Director
Transaction date
Proposed sale
Price
18.79
Quantity 30,000
Value US$563,553
3.3
Catinazzo Thomas Chief Financial Officer Officer
Transaction date
Sale
Price
18.61
Quantity 1,459 -0.9%
Value US$27,152
3.2
Rahmer Peter See remarks Officer
Transaction date
Sale
Price
18.61
Quantity 748 -0.3%
Value US$13,920
3.3
Bergstrom Donald A President, R&D Officer
Transaction date
Sale
Price
18.61
Quantity 2,237 -0.5%
Value US$41,631
SEKAR KATHIRESAN Director Non-Executive Director
Transaction date
Proposed sale
Price
19.81
Quantity 30,000
Value US$594,414
SEKAR KATHIRESAN Director Non-Executive Director
Transaction date
Proposed sale
Price
19.58
Quantity 66,055
Value US$1,293,555
2.5
Patel Sanjiv President and CEO Executive Director
Transaction date
Planned sale
Price
19.58
Quantity 48,199 -7.3%
Value US$943,736
2.5
SANJIV PATEL Director; Officer Executive Director
Transaction date
Proposed sale
Price
18.90
Quantity 144,597
Value US$2,732,883
3.3
Bergstrom Donald A President, R&D Officer
Transaction date
Planned sale
Price
18.71
Quantity 8,660 -2.1%
Value US$162,029
3.3
Catinazzo Thomas Chief Financial Officer Officer
Transaction date
Planned sale
Price
18.69
Quantity 17,717 -10.0%
Value US$331,131
3.2
Rahmer Peter See remarks Officer
Transaction date
Planned sale
Price
19.09
Quantity 50,000 -18.1%
Value US$954,500
3.2
PETER RAHMER Officer Officer
Transaction date
Proposed sale
Price
19.74
Quantity 50,000
Value US$987,000
3.3
Catinazzo Thomas Chief Financial Officer Officer
Transaction date
Planned sale
Price
16.97
Quantity 51,560 -22.5%
Value US$874,973
3.3
Catinazzo Thomas Chief Financial Officer Officer
Transaction date
Planned sale
Price
16.97
Quantity 61,563 -25.8%
Value US$1,044,724
3.3
Catinazzo Thomas Chief Financial Officer Officer
Transaction date
Planned sale
Price
16.97
Quantity 56,323 -24.1%
Value US$955,801
3.3
Catinazzo Thomas Chief Financial Officer Officer
Transaction date
Planned sale
Price
17.01
Quantity 17,717 -9.1%
Value US$301,366
3.3
Bergstrom Donald A President, R&D Officer
Transaction date
Planned sale
Price
16.94
Quantity 93,456 -18.3%
Value US$1,583,145
3.3
DONALD BERGSTROM Officer Officer
Transaction date
Proposed sale
Price
15.88
Quantity 110,646
Value US$1,757,058
3.3
DONALD BERGSTROM Officer Officer
Transaction date
Proposed sale
Price
15.88
Quantity 110,646
Value US$1,757,058
3.3
THOMAS CATINAZZO Officer Officer
Transaction date
Proposed sale
Price
15.88
Quantity 204,880
Value US$3,253,494
3.3
THOMAS CATINAZZO Officer Officer
Transaction date
Proposed sale
Price
15.88
Quantity 204,880
Value US$3,253,494
3.3
Catinazzo Thomas Chief Financial Officer Officer
Transaction date
Planned sale
Price
12.86
Quantity 17,717 -8.3%
Value US$227,841
3.3
THOMAS CATINAZZO Officer Officer
Transaction date
Proposed sale
Price
13.22
Quantity 37,234
Value US$492,233
3.3
Bergstrom Donald A President, R&D Officer
Transaction date
Sale
Price
14.79
Quantity 1,490 -0.4%
Value US$22,037
3.2
Rahmer Peter See remarks Officer
Transaction date
Sale
Price
14.79
Quantity 753 -0.3%
Value US$11,137
3.3
Catinazzo Thomas Chief Financial Officer Officer
Transaction date
Sale
Price
14.79
Quantity 972 -0.5%
Value US$14,376
3.3
Catinazzo Thomas Chief Financial Officer Officer
Transaction date
Planned sale
Price
15.00
Quantity 1,800 -0.8%
Value US$27,000
3.3
Catinazzo Thomas Chief Financial Officer Officer
Transaction date
Planned sale
Price
13.01
Quantity 17,717 -7.7%
Value US$230,498
3.3
Catinazzo Thomas Chief Financial Officer Officer
Transaction date
Planned sale
Price
10.06
Quantity 17,717 -7.1%
Value US$178,233
3.3
THOMAS CATINAZZO Officer Officer
Transaction date
Proposed sale
Price
9.89
Quantity 53,151
Value US$525,663
3.3
Bergstrom Donald A President, R&D Officer
Transaction date
Sale
Price
8.45
Quantity 2,686 -0.6%
Value US$22,697
3.2
Rahmer Peter See remarks Officer
Transaction date
Sale
Price
8.45
Quantity 1,354 -0.5%
Value US$11,441
3.3
Catinazzo Thomas Chief Financial Officer Officer
Transaction date
Sale
Price
8.45
Quantity 1,695 -0.7%
Value US$14,323
3.3
Bergstrom Donald A President, R&D Officer
Transaction date
Sale
Price
7.62
Quantity 18,895 -4.3%
Value US$143,980
3.2
Rahmer Peter See remarks Officer
Transaction date
Sale
Price
7.62
Quantity 11,684 -4.0%
Value US$89,032
3.3
Catinazzo Thomas Chief Financial Officer Officer
Transaction date
Sale
Price
7.62
Quantity 13,820 -5.2%
Value US$105,308
2.5
Patel Sanjiv President and CEO Executive Director
Transaction date
Sale
Price
7.82
Quantity 43,168 -6.1%
Value US$337,574
2.5
Patel Sanjiv President and CEO Executive Director
Transaction date
Sale
Price
7.00
Quantity 62,073 -8.1%
Value US$434,511
3.2
Rahmer Peter See remarks Officer
Transaction date
Sale
Price
7.50
Quantity 21,394 -6.0%
Value US$160,455
3.2
Peter J Rahmer Officer Officer
Transaction date
Proposed sale
Price
7.50
Quantity 21,394
Value US$160,436
3.2
Rahmer Peter See remarks Officer
Transaction date
Sale
Price
7.29
Quantity 19,135 -5.1%
Value US$139,494
3.3
Bergstrom Donald A President, R&D Officer
Transaction date
Sale
Price
7.29
Quantity 30,897 -5.6%
Value US$225,239
3.3
Catinazzo Thomas Chief Financial Officer Officer
Transaction date
Sale
Price
7.29
Quantity 21,664 -6.5%
Value US$157,931
2.5
Patel Sanjiv President and CEO Executive Director
Transaction date
Sale
Price
3.57
Quantity 18,639 -2.4%
Value US$66,541
2.5
Patel Sanjiv President and CEO Executive Director
Transaction date
Sale
Price
3.57
Quantity 42,740 -5.2%
Value US$152,582
3.3
Bergstrom Donald A President, R&D Officer
Transaction date
Sale
Price
3.00
Quantity 27,472 -4.5%
Value US$82,416
3.2
Rahmer Peter See remarks Officer
Transaction date
Sale
Price
3.00
Quantity 10,739 -2.7%
Value US$32,217
4.3
Adams Brian Chief Legal Officer Officer
Transaction date
Sale
Price
3.00
Quantity 12,943 -3.2%
Value US$38,829
3.3
Catinazzo Thomas Chief Financial Officer Officer
Transaction date
Sale
Price
3.00
Quantity 12,943 -3.5%
Value US$38,829
3.3
Catinazzo Thomas Chief Financial Officer Officer
Transaction date
Planned sale
Price
3.23
Quantity 3,558 -1.0%
Value US$11,492
3.3
THOMAS J CATINAZZO Officer Officer
Transaction date
Proposed sale
Price
3.23
Quantity 3,558
Value US$11,492
3.3
Bergstrom Donald A President, R&D Officer
Transaction date
Sale
Price
3.17
Quantity 4,090 -0.7%
Value US$12,965
3.2
Rahmer Peter See remarks Officer
Transaction date
Sale
Price
3.17
Quantity 1,364 -0.3%
Value US$4,324
4.3
Adams Brian Chief Legal Officer Officer
Transaction date
Sale
Price
3.17
Quantity 1,644 -0.4%
Value US$5,211
3.3
Catinazzo Thomas Chief Financial Officer Officer
Transaction date
Planned sale
Price
3.17
Quantity 981 -0.3%
Value US$3,110
3.3
Catinazzo Thomas Chief Financial Officer Officer
Transaction date
Sale
Price
3.17
Quantity 1,709 -0.5%
Value US$5,418
3.3
THOMAS J CATINAZZO Officer Officer
Transaction date
Proposed sale
Price
3.17
Quantity 981
Value US$3,110
2.5
Patel Sanjiv President and CEO Executive Director
Transaction date
Sale
Price
2.97
Quantity 18,653 -2.2%
Value US$55,399
2.5
Patel Sanjiv President and CEO Executive Director
Transaction date
Sale
Price
2.97
Quantity 42,769 -4.8%
Value US$127,024
3.2
Rahmer Peter See remarks Officer
Transaction date
Sale
Price
2.84
Quantity 247 -0.1%
Value US$701
3.3
Bergstrom Donald A President, R&D Officer
Transaction date
Sale
Price
2.84
Quantity 986 -0.2%
Value US$2,800
3.3
Catinazzo Thomas Chief Financial Officer Officer
Transaction date
Planned sale
Price
2.84
Quantity 4,566 -1.2%
Value US$12,967
3.3
Catinazzo Thomas Chief Financial Officer Officer
Transaction date
Sale
Price
2.84
Quantity 298 -0.1%
Value US$846
4.3
Adams Brian Chief Legal Officer Officer
Transaction date
Sale
Price
2.84
Quantity 298 -0.1%
Value US$846
3.3
THOMAS J CATINAZZO Officer Officer
Transaction date
Proposed sale
Price
2.84
Quantity 4,566
Value US$12,967
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-09 2026-09-08 PlS Planned sale
3.3
Bergstrom Donald A

President, R&D

Officer
69,817 -44.3%
332.47
US$4,569,701 		69,817 -44.3% 332.47 US$4,569,701
2026-09-09 2026-09-08 PlS Planned sale
3.3
Catinazzo Thomas

Chief Financial Officer

Officer
38,156 +9.6%
328.00
US$1,512,895 		38,156 +9.6% 328.00 US$1,512,895
2026-09-09 2026-09-08 PlS Planned sale
2.5
Patel Sanjiv

President and CEO

Executive Director
13,289 +31.2%
177.03
US$1,223,187 		13,289 +31.2% 177.03 US$1,223,187
2026-08-28 2026-08-26 PlS Planned sale
3.2
Rahmer Peter

See remarks

Officer
4,508 -2.0%
20.03
US$90,295 		4,508 -2.0% 20.03 US$90,295
2026-08-26 2026-08-26 PrS Proposed sale
3.2
PETER RAHMER

Officer

Officer
50,000
20.57
US$1,028,500 		50,000 20.57 US$1,028,500
2026-08-28 2026-08-25 S Sale
SVF Pauling (Cayman) Ltd
Large shareholder
6,000,000 -21.5%
19.40
US$116,400,000 		6,000,000 -21.5% 19.40 US$116,400,000
2026-08-25 2026-08-25 PrS Proposed sale
SVF Pauling (Cayman) Ltd

Stockholder

Large shareholder
6,000,000
20.57
US$123,420,000 		6,000,000 20.57 US$123,420,000
2026-08-18 2026-08-17 PlS Planned sale
2.5
Patel Sanjiv

President and CEO

Executive Director
48,199 -7.8%
20.33
US$979,886 		48,199 -7.8% 20.33 US$979,886
2026-08-18 2026-08-14 PlS Planned sale
3.3
Catinazzo Thomas

Chief Financial Officer

Officer
17,717 -11.2%
19.74
US$349,734 		17,717 -11.2% 19.74 US$349,734
2026-08-04 2026-08-04 PrS Proposed sale
SEKAR KATHIRESAN

Director

Non-Executive Director
42,225
19.57
US$826,466 		42,225 19.57 US$826,466
2026-07-31 2026-07-31 PrS Proposed sale
SEKAR KATHIRESAN

Director

Non-Executive Director
30,000
18.79
US$563,553 		30,000 18.79 US$563,553
2026-07-30 2026-07-28 S Sale
3.3
Catinazzo Thomas

Chief Financial Officer

Officer
1,459 -0.9%
18.61
US$27,152 		1,459 -0.9% 18.61 US$27,152
2026-07-30 2026-07-28 S Sale
3.2
Rahmer Peter

See remarks

Officer
748 -0.3%
18.61
US$13,920 		748 -0.3% 18.61 US$13,920
2026-07-30 2026-07-28 S Sale
3.3
Bergstrom Donald A

President, R&D

Officer
2,237 -0.5%
18.61
US$41,631 		2,237 -0.5% 18.61 US$41,631
2026-07-21 2026-07-21 PrS Proposed sale
SEKAR KATHIRESAN

Director

Non-Executive Director
30,000
19.81
US$594,414 		30,000 19.81 US$594,414
2026-07-20 2026-07-20 PrS Proposed sale
SEKAR KATHIRESAN

Director

Non-Executive Director
66,055
19.58
US$1,293,555 		66,055 19.58 US$1,293,555
2026-07-08 2026-07-07 PlS Planned sale
2.5
Patel Sanjiv

President and CEO

Executive Director
48,199 -7.3%
19.58
US$943,736 		48,199 -7.3% 19.58 US$943,736
2026-07-07 2026-07-07 PrS Proposed sale
2.5
SANJIV PATEL

Director; Officer

Executive Director
144,597
18.90
US$2,732,883 		144,597 18.90 US$2,732,883
2026-07-08 2026-07-06 PlS Planned sale
3.3
Bergstrom Donald A

President, R&D

Officer
8,660 -2.1%
18.71
US$162,029 		8,660 -2.1% 18.71 US$162,029
2026-07-08 2026-07-06 PlS Planned sale
3.3
Catinazzo Thomas

Chief Financial Officer

Officer
17,717 -10.0%
18.69
US$331,131 		17,717 -10.0% 18.69 US$331,131
2026-07-02 2026-06-30 PlS Planned sale
3.2
Rahmer Peter

See remarks

Officer
50,000 -18.1%
19.09
US$954,500 		50,000 -18.1% 19.09 US$954,500
2026-06-30 2026-06-30 PrS Proposed sale
3.2
PETER RAHMER

Officer

Officer
50,000
19.74
US$987,000 		50,000 19.74 US$987,000
2026-06-24 2026-06-22 PlS Planned sale
3.3
Catinazzo Thomas

Chief Financial Officer

Officer
51,560 -22.5%
16.97
US$874,973 		51,560 -22.5% 16.97 US$874,973
2026-06-24 2026-06-22 PlS Planned sale
3.3
Catinazzo Thomas

Chief Financial Officer

Officer
61,563 -25.8%
16.97
US$1,044,724 		61,563 -25.8% 16.97 US$1,044,724
2026-06-24 2026-06-22 PlS Planned sale
3.3
Catinazzo Thomas

Chief Financial Officer

Officer
56,323 -24.1%
16.97
US$955,801 		56,323 -24.1% 16.97 US$955,801
2026-06-24 2026-06-22 PlS Planned sale
3.3
Catinazzo Thomas

Chief Financial Officer

Officer
17,717 -9.1%
17.01
US$301,366 		17,717 -9.1% 17.01 US$301,366
2026-06-24 2026-06-22 PlS Planned sale
3.3
Bergstrom Donald A

President, R&D

Officer
93,456 -18.3%
16.94
US$1,583,145 		93,456 -18.3% 16.94 US$1,583,145
2026-06-22 2026-06-22 PrS Proposed sale
3.3
DONALD BERGSTROM

Officer

Officer
110,646
15.88
US$1,757,058 		110,646 15.88 US$1,757,058
2026-06-22 2026-06-22 PrS Proposed sale
3.3
DONALD BERGSTROM

Officer

Officer
110,646
15.88
US$1,757,058 		110,646 15.88 US$1,757,058
2026-06-22 2026-06-22 PrS Proposed sale
3.3
THOMAS CATINAZZO

Officer

Officer
204,880
15.88
US$3,253,494 		204,880 15.88 US$3,253,494
2026-06-22 2026-06-22 PrS Proposed sale
3.3
THOMAS CATINAZZO

Officer

Officer
204,880
15.88
US$3,253,494 		204,880 15.88 US$3,253,494
2026-05-14 2026-05-14 PlS Planned sale
3.3
Catinazzo Thomas

Chief Financial Officer

Officer
17,717 -8.3%
12.86
US$227,841 		17,717 -8.3% 12.86 US$227,841
2026-05-14 2026-05-14 PrS Proposed sale
3.3
THOMAS CATINAZZO

Officer

Officer
37,234
13.22
US$492,233 		37,234 13.22 US$492,233
2026-04-30 2026-04-28 S Sale
3.3
Bergstrom Donald A

President, R&D

Officer
1,490 -0.4%
14.79
US$22,037 		1,490 -0.4% 14.79 US$22,037
2026-04-30 2026-04-28 S Sale
3.2
Rahmer Peter

See remarks

Officer
753 -0.3%
14.79
US$11,137 		753 -0.3% 14.79 US$11,137
2026-04-30 2026-04-28 S Sale
3.3
Catinazzo Thomas

Chief Financial Officer

Officer
972 -0.5%
14.79
US$14,376 		972 -0.5% 14.79 US$14,376
2026-04-09 2026-04-09 PlS Planned sale
3.3
Catinazzo Thomas

Chief Financial Officer

Officer
1,800 -0.8%
15.00
US$27,000 		1,800 -0.8% 15.00 US$27,000
2026-04-09 2026-04-07 PlS Planned sale
3.3
Catinazzo Thomas

Chief Financial Officer

Officer
17,717 -7.7%
13.01
US$230,498 		17,717 -7.7% 13.01 US$230,498
2026-03-11 2026-03-09 PlS Planned sale
3.3
Catinazzo Thomas

Chief Financial Officer

Officer
17,717 -7.1%
10.06
US$178,233 		17,717 -7.1% 10.06 US$178,233
2026-03-09 2026-03-09 PrS Proposed sale
3.3
THOMAS CATINAZZO

Officer

Officer
53,151
9.89
US$525,663 		53,151 9.89 US$525,663
2026-01-29 2026-01-28 S Sale
3.3
Bergstrom Donald A

President, R&D

Officer
2,686 -0.6%
8.45
US$22,697 		2,686 -0.6% 8.45 US$22,697
2026-01-29 2026-01-28 S Sale
3.2
Rahmer Peter

See remarks

Officer
1,354 -0.5%
8.45
US$11,441 		1,354 -0.5% 8.45 US$11,441
2026-01-29 2026-01-28 S Sale
3.3
Catinazzo Thomas

Chief Financial Officer

Officer
1,695 -0.7%
8.45
US$14,323 		1,695 -0.7% 8.45 US$14,323
2026-01-29 2026-01-27 S Sale
3.3
Bergstrom Donald A

President, R&D

Officer
18,895 -4.3%
7.62
US$143,980 		18,895 -4.3% 7.62 US$143,980
2026-01-29 2026-01-27 S Sale
3.2
Rahmer Peter

See remarks

Officer
11,684 -4.0%
7.62
US$89,032 		11,684 -4.0% 7.62 US$89,032
2026-01-29 2026-01-27 S Sale
3.3
Catinazzo Thomas

Chief Financial Officer

Officer
13,820 -5.2%
7.62
US$105,308 		13,820 -5.2% 7.62 US$105,308
2026-01-07 2026-01-06 S Sale
2.5
Patel Sanjiv

President and CEO

Executive Director
43,168 -6.1%
7.82
US$337,574 		43,168 -6.1% 7.82 US$337,574
2025-11-04 2025-11-03 S Sale
2.5
Patel Sanjiv

President and CEO

Executive Director
62,073 -8.1%
7.00
US$434,511 		62,073 -8.1% 7.00 US$434,511
2025-10-30 2025-10-29 S Sale
3.2
Rahmer Peter

See remarks

Officer
21,394 -6.0%
7.50
US$160,455 		21,394 -6.0% 7.50 US$160,455
2025-10-29 2025-10-29 PrS Proposed sale
3.2
Peter J Rahmer

Officer

Officer
21,394
7.50
US$160,436 		21,394 7.50 US$160,436
2025-10-30 2025-10-28 S Sale
3.2
Rahmer Peter

See remarks

Officer
19,135 -5.1%
7.29
US$139,494 		19,135 -5.1% 7.29 US$139,494
2025-10-30 2025-10-28 S Sale
3.3
Bergstrom Donald A

President, R&D

Officer
30,897 -5.6%
7.29
US$225,239 		30,897 -5.6% 7.29 US$225,239
2025-10-30 2025-10-28 S Sale
3.3
Catinazzo Thomas

Chief Financial Officer

Officer
21,664 -6.5%
7.29
US$157,931 		21,664 -6.5% 7.29 US$157,931
2025-07-10 2025-07-09 S Sale
2.5
Patel Sanjiv

President and CEO

Executive Director
18,639 -2.4%
3.57
US$66,541 		18,639 -2.4% 3.57 US$66,541
2025-07-10 2025-07-09 S Sale
2.5
Patel Sanjiv

President and CEO

Executive Director
42,740 -5.2%
3.57
US$152,582 		42,740 -5.2% 3.57 US$152,582
2025-04-30 2025-04-30 S Sale
3.3
Bergstrom Donald A

President, R&D

Officer
27,472 -4.5%
3.00
US$82,416 		27,472 -4.5% 3.00 US$82,416
2025-04-30 2025-04-30 S Sale
3.2
Rahmer Peter

See remarks

Officer
10,739 -2.7%
3.00
US$32,217 		10,739 -2.7% 3.00 US$32,217
2025-04-30 2025-04-30 S Sale
4.3
Adams Brian

Chief Legal Officer

Officer
12,943 -3.2%
3.00
US$38,829 		12,943 -3.2% 3.00 US$38,829
2025-04-30 2025-04-30 S Sale
3.3
Catinazzo Thomas

Chief Financial Officer

Officer
12,943 -3.5%
3.00
US$38,829 		12,943 -3.5% 3.00 US$38,829
2025-04-30 2025-04-29 PlS Planned sale
3.3
Catinazzo Thomas

Chief Financial Officer

Officer
3,558 -1.0%
3.23
US$11,492 		3,558 -1.0% 3.23 US$11,492
2025-04-29 2025-04-29 PrS Proposed sale
3.3
THOMAS J CATINAZZO

Officer

Officer
3,558
3.23
US$11,492 		3,558 3.23 US$11,492
2025-04-30 2025-04-28 S Sale
3.3
Bergstrom Donald A

President, R&D

Officer
4,090 -0.7%
3.17
US$12,965 		4,090 -0.7% 3.17 US$12,965
2025-04-30 2025-04-28 S Sale
3.2
Rahmer Peter

See remarks

Officer
1,364 -0.3%
3.17
US$4,324 		1,364 -0.3% 3.17 US$4,324
2025-04-30 2025-04-28 S Sale
4.3
Adams Brian

Chief Legal Officer

Officer
1,644 -0.4%
3.17
US$5,211 		1,644 -0.4% 3.17 US$5,211
2025-04-30 2025-04-28 PlS Planned sale
3.3
Catinazzo Thomas

Chief Financial Officer

Officer
981 -0.3%
3.17
US$3,110 		981 -0.3% 3.17 US$3,110
2025-04-30 2025-04-28 S Sale
3.3
Catinazzo Thomas

Chief Financial Officer

Officer
1,709 -0.5%
3.17
US$5,418 		1,709 -0.5% 3.17 US$5,418
2025-04-28 2025-04-28 PrS Proposed sale
3.3
THOMAS J CATINAZZO

Officer

Officer
981
3.17
US$3,110 		981 3.17 US$3,110
2025-04-24 2025-04-23 S Sale
2.5
Patel Sanjiv

President and CEO

Executive Director
18,653 -2.2%
2.97
US$55,399 		18,653 -2.2% 2.97 US$55,399
2025-04-24 2025-04-23 S Sale
2.5
Patel Sanjiv

President and CEO

Executive Director
42,769 -4.8%
2.97
US$127,024 		42,769 -4.8% 2.97 US$127,024
2025-03-31 2025-03-27 S Sale
3.2
Rahmer Peter

See remarks

Officer
247 -0.1%
2.84
US$701 		247 -0.1% 2.84 US$701
2025-03-31 2025-03-27 S Sale
3.3
Bergstrom Donald A

President, R&D

Officer
986 -0.2%
2.84
US$2,800 		986 -0.2% 2.84 US$2,800
2025-03-31 2025-03-27 PlS Planned sale
3.3
Catinazzo Thomas

Chief Financial Officer

Officer
4,566 -1.2%
2.84
US$12,967 		4,566 -1.2% 2.84 US$12,967
2025-03-31 2025-03-27 S Sale
3.3
Catinazzo Thomas

Chief Financial Officer

Officer
298 -0.1%
2.84
US$846 		298 -0.1% 2.84 US$846
2025-03-31 2025-03-27 S Sale
4.3
Adams Brian

Chief Legal Officer

Officer
298 -0.1%
2.84
US$846 		298 -0.1% 2.84 US$846
2025-03-27 2025-03-27 PrS Proposed sale
3.3
THOMAS J CATINAZZO

Officer

Officer
4,566
2.84
US$12,967 		4,566 2.84 US$12,967
Explore more

More insider trading research around Relay Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America